Concepedia

Christophe Hézode

CH

Statistics

Publications

142

Citations

17K

H-Index

65

Active since

1998

Affiliations

Inserm(Current)

Université Paris-Est Créteil

Assistance Publique – Hôpitaux de Paris

Université Paris Cité

Sorbonne Université

Christophe Hézode is an author at Inserm specializing in viral hepatitis, antiviral therapy, and virology.

ORCID

Publications per year

1998–2023

142

Publications

142

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

Jordan J. Feld, Ira M. Jacobson, Christophe Hézode et al. · New England Journal of Medicine · 2015 · 1.1K citations · Full text

, , +17

Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection

Christophe Hézode, Nicole Forestier, Geoffrey Dusheiko et al. · New England Journal of Medicine · 2009 · 1K citations

, , +12

ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis

Fred Poordad, Christophe Hézode, Roger Trinh et al. · New England Journal of Medicine · 2014 · 877 citations · Full text

, , +17

Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3

Stefan Zeuzem, Geoffrey Dusheiko, Riina Salupere et al. · New England Journal of Medicine · 2014 · 798 citations · Full text

, , +17

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

Fabrice Carrat, Hélène Fontaine, Céline Dorival et al. · The Lancet · 2019 · 631 citations · Full text

, , +13

1–5 of 142